Decades before anyone knew him as the CEO and chair who led Edwards Lifesciences as it commercialized transcatheter aortic valve replacement (TAVR), Mike Mussallem was a chemical engineering grad in ...

"This is going to be a broad approach. ... There's a big list to go after, but we're committed to make a difference," ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...